Matrix Partners China has invested in the Series B round of Chinese e-commerce platform xyb2b.com while Elpiscience Biopharmaceuticals has secured funding from Hillhouse Capital.
Matrix Partners China invests in xyb2b.com
New investors joining the funding round include Hongtai Capital Holdings and GX Capital while its existing investors Eastern Bell Venture Capital, GSR United Capital and Dongzhao Shanghai Group also participated in the round.
Established in 2015, xyb2b.com provides one-stop supply chain services for cross-border purchases.
The platform raised $47 million in a Series A round led by GSR Ventures and Eastern Bell Venture earlier this year.
According to Crunchbase, other backers of xyb2b.com include Hongtai Capital, Matrix Partners China, GSR United Capital, GX Capital and Dongzhao Shanghai Group.
Elpiscience raises $35m led by Hillhouse Capital
Elpiscience Biopharmaceuticals Company, a developer of immunotherapies to fight cancer, has raised a $35-million Series A+ round of financing led by Beijing-based investment firm Hillhouse Capital, according to the China Money Network.
Others participating in the round include Hong Kong-based CDH Investments and its existing investor Lilly Asia Ventures from China which led a $20-million Series A in Elpiscience last year.
Focused on Asia, Hillhouse, an early backer of well-known firms like Tencent, Baidu, JD.com, Uber and Airbnb, has recently announced the close of Hillhouse Fund IV at an aggregate commitment of $10.6 billion.